Nanoemulsions as non-viral vectors of the CRISPR/Cas9 system aiming for MPS I gene editing

被引：0
|
作者：
Schuh, R. S. [1 ]
Carvalho, T. G. [1 ]
Bidone, J. [1 ]
Pasqualim, G. [1 ]
Diel, D. [1 ]
Teixeira, H. F. [1 ]
Baldo, G. [1 ]
机构：
[1] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil
来源：
HUMAN GENE THERAPY | 2016年 / 27卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P291
引用
收藏
页码：A134 / A134
页数：1
相关论文
共 50 条
  • [1] Non-viral Delivery of CRISPR/Cas9 Genome Editing
    Sheng, Jinhan
    Zheng, Qizhen
    Wang, Ming
    CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE, 2023, 44 (03):
  • [2] Pre-clinical non-viral vectors exploited for in vivo CRISPR/Cas9 gene editing: an overview
    Rouatbi, Nadia
    McGlynn, Tasneem
    Al-Jamal, Khuloud T.
    BIOMATERIALS SCIENCE, 2022, 10 (13) : 3410 - 3432
  • [3] Non-viral delivery of CRISPR–Cas9 complexes for targeted gene editing via a polymer delivery system
    Jonathan O’Keeffe Ahern
    Irene Lara-Sáez
    Dezhong Zhou
    Rodolfo Murillas
    Jose Bonafont
    Ángeles Mencía
    Marta García
    Darío Manzanares
    Jennifer Lynch
    Ruth Foley
    Qian Xu
    A Sigen
    Fernando Larcher
    Wenxin Wang
    Gene Therapy, 2022, 29 : 157 - 170
  • [4] Non-viral nanocarriers for CRISPR-Cas9 gene editing system delivery
    Tang, Xuefeng
    Wang, Zhao
    Zhang, Ying
    Mu, Wei
    Han, Xiaojun
    CHEMICAL ENGINEERING JOURNAL, 2022, 435
  • [5] Polyethylenimine based magnetic nanoparticles mediated non-viral CRISPR/Cas9 system for genome editing
    Rohiwal, S. S.
    Dvorakova, N.
    Klima, J.
    Vaskovicova, M.
    Senigl, F.
    Slouf, M.
    Pavlova, E.
    Stepanek, P.
    Babuka, D.
    Benes, H.
    Ellederova, Z.
    Stieger, K.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [6] Polyethylenimine based magnetic nanoparticles mediated non-viral CRISPR/Cas9 system for genome editing
    S. S. Rohiwal
    N. Dvorakova
    J. Klima
    M. Vaskovicova
    F. Senigl
    M. Slouf
    E. Pavlova
    P. Stepanek
    D. Babuka
    H. Benes
    Z. Ellederova
    K. Stieger
    Scientific Reports, 10
  • [7] CRISPR/CAS9 GENE EDITING
    不详
    CHEMICAL & ENGINEERING NEWS, 2015, : 26 - 27
  • [8] CGMP-COMPLIANT, CLINICAL SCALE, NON-VIRAL PLATFORM FOR EFFICIENT GENE EDITING USING CRISPR/CAS9
    Li, L.
    Natarajan, P.
    Allen, C.
    Peshwa, M. V.
    CYTOTHERAPY, 2014, 16 (04) : S37 - S37
  • [9] Effective prevention of atherosclerosis by non-viral delivery of CRISPR/ Cas9
    Xu, Chen
    Zhang, Xiaoping
    Yang, Weijie
    Gao, Shijuan
    Zhao, Nana
    Li, Ping
    Du, Jie
    Li, Yulin
    Xu, Fu-Jian
    NANO TODAY, 2024, 54
  • [10] Non-Viral CRISPR/Cas Gene Editing In Vitro and In Vivo Enabled by Synthetic Nanoparticle Co-Delivery of Cas9 mRNA and sgRNA
    Miller, Jason B.
    Zhang, Shuyuan
    Kos, Petra
    Xiong, Hu
    Zhou, Kejin
    Perelman, Sofya S.
    Zhu, Hao
    Siegwart, Daniel J.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2017, 56 (04) : 1059 - 1063
12345